SCHEMBL9312376

SCHEMBL9312376

C1=CNN(N2CCNCC2)C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1420014 0.67 HTR3E (0.30)
SCHEMBL9485285 0.67
SCHEMBL2356063 0.63 HIF1A (0.42)
SCHEMBL1239517 0.61 HTR3E (0.30)
Hydrochloric Acid SCHEMBL28856596 0.60 ALDH1A1 (0.39)
SCHEMBL28470549 0.60 HIF1A (0.50)
SCHEMBL238766 0.60 HIF1A (0.39)
SCHEMBL3824518 0.60
SCHEMBL7052608 0.60 HIF1A (0.50)
SCHEMBL29001721 0.58 HIF1A (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5292738-A Anti-virally active pyridazinamines JANSSEN PHARMACEUTICA N.V. (BE) 1994-03-08 US disclosed
US-5157035-A Viricides JANSSEN PHARMACEUTICA N. V. (BE) 1992-10-20 US disclosed
EP-0156433-B1 ANTI-VIRALLY ACTIVE PYRIDAZINAMINES JANSSEN PHARMACEUTICA N.V. (BE) 1991-02-27 EP disclosed
EP-0211457-A2 Novel (4-substituted-piperazinyl)pyridazines JANSSEN PHARMACEUTICA N.V. (BE) 1987-02-25 EP disclosed
CN-86105558-A The preparation method of new (4-replaces-piperazinyl) pyridazine class 1987-01-28 CN disclosed
EP-0156433-A2 Anti-virally active pyridazinamines JANSSEN PHARMACEUTICA N.V. (BE) 1985-10-02 EP disclosed